- Investing Ideas
- Swedish Pharmaceuticals & Biotech Healthy potentially undervalued
Swedish Pharmaceuticals & Biotech Healthy potentially undervalued
Results
4
Companies which are potentially undervalued and in an acceptable financial position.
4 companies
Camurus
Market Cap: SEK 33.7b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 565.50
7D
4.3%
1Y
-6.8%
Vitrolife
Market Cap: SEK 11.9b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 87.75
7D
0.3%
1Y
-37.9%
Swedish Orphan Biovitrum
Market Cap: SEK 159.8b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 462.00
7D
-0.9%
1Y
62.0%
Bonesupport Holding
Market Cap: SEK 13.9b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 211.40
7D
4.6%
1Y
-24.0%